Slc51b Rat (-)-epigallocatechin 3-gallate multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of SLC51B mRNA]; epigallocatechin more ... CTD PMID:22178739 Slc51b Rat (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 Slc51b Rat (R)-pantothenic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Pantothenic Acid results in increased expression of SLC51B mRNA CTD PMID:19397697 Slc51b Rat (S)-colchicine decreases expression ISO Slc51b (Mus musculus) 6480464 Colchicine results in decreased expression of SLC51B mRNA CTD PMID:38311468 Slc51b Rat 1,1-dichloroethene decreases expression ISO Slc51b (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC51B mRNA CTD PMID:26682919 Slc51b Rat 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene multiple interactions ISO Slc51b (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Slc51b Rat 1,2-dimethylhydrazine decreases expression ISO Slc51b (Mus musculus) 6480464 1,2-Dimethylhydrazine results in decreased expression of SLC51B mRNA CTD PMID:22206623 Slc51b Rat 1-naphthyl isothiocyanate increases expression ISO Slc51b (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA CTD PMID:19407337|PMID:27853831|PMID:28549656|PMID:30352267|PMID:30517764|PMID:33749747|PMID:37968239 Slc51b Rat 1-naphthyl isothiocyanate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; [1-Naphthylisothiocyanate co-treated more ... CTD PMID:28549656|PMID:30352267|PMID:33749747|PMID:36787806|PMID:37968239 Slc51b Rat 1-naphthyl isothiocyanate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat 17alpha-ethynylestradiol multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 Slc51b Rat 17alpha-ethynylestradiol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat 17beta-estradiol increases expression ISO SLC51B (Homo sapiens) 6480464 Estradiol results in increased expression of SLC51B mRNA CTD PMID:20106945 Slc51b Rat 17beta-estradiol increases expression ISO Slc51b (Mus musculus) 6480464 Estradiol results in increased expression of SLC51B mRNA CTD PMID:39298647 Slc51b Rat 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO SLC51B (Homo sapiens) 6480464 2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of SLC51B mRNA CTD PMID:20638727 Slc51b Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Slc51b Rat 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Slc51b (Mus musculus) 6480464 ESR1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SLC51B more ... CTD PMID:29112739 Slc51b Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Slc51b (Mus musculus) 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SLC51B mRNA CTD PMID:29112739 Slc51b Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC51B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:20106945|PMID:21632981 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC51B mRNA CTD PMID:33387578 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:29452137 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc51b (Mus musculus) 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA] CTD PMID:29452137 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC51B mRNA CTD PMID:26377647 Slc51b Rat 2,4,4'-trichlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Slc51b Rat 3,3',5-triiodo-L-thyronine increases expression ISO SLC51B (Homo sapiens) 6480464 Triiodothyronine results in increased expression of SLC51B mRNA CTD PMID:21815645 Slc51b Rat 3,3',5-triiodo-L-thyronine multiple interactions ISO SLC51B (Homo sapiens) 6480464 (4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid inhibits the reaction [Triiodothyronine results in increased expression of SLC51B mRNA] CTD PMID:21815645 Slc51b Rat 4,4'-sulfonyldiphenol increases expression ISO Slc51b (Mus musculus) 6480464 bisphenol S results in increased expression of SLC51B mRNA CTD PMID:39298647 Slc51b Rat 4,4'-sulfonyldiphenol increases methylation ISO Slc51b (Mus musculus) 6480464 bisphenol S results in increased methylation of SLC51B promoter CTD PMID:33297965 Slc51b Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc51b (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC51B mRNA CTD PMID:33297965 Slc51b Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC51B mRNA CTD PMID:24780913 Slc51b Rat 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of SLC51B mRNA CTD PMID:33749747 Slc51b Rat aflatoxin B1 increases expression ISO SLC51B (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC51B mRNA CTD PMID:21632981|PMID:21641981 Slc51b Rat allocholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 allocholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:37968239 Slc51b Rat allopurinol multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of SLC51B mRNA CTD PMID:33749747 Slc51b Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of SLC51B mRNA CTD PMID:23912714 Slc51b Rat arsane decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 Slc51b Rat arsenic atom decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 Slc51b Rat atazanavir sulfate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650 Slc51b Rat Azoxymethane multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B more ... CTD PMID:29950665 Slc51b Rat aztreonam decreases expression ISO Slc51b (Mus musculus) 6480464 Aztreonam results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat benzo[a]pyrene increases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC51B mRNA CTD PMID:21632981 Slc51b Rat benzo[a]pyrene decreases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC51B mRNA CTD PMID:32234424 Slc51b Rat benzo[a]pyrene increases methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC51B exon; Benzo(a)pyrene results in increased methylation of SLC51B more ... CTD PMID:27901495 Slc51b Rat benzo[a]pyrene affects methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC51B 5' UTR CTD PMID:27901495 Slc51b Rat benzo[a]pyrene diol epoxide I increases expression ISO SLC51B (Homo sapiens) 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC51B mRNA CTD PMID:26238291 Slc51b Rat beta-hexachlorocyclohexane decreases expression ISO Slc51b (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of SLC51B mRNA CTD PMID:28392238 Slc51b Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:25181051 Slc51b Rat bisphenol A affects expression ISO SLC51B (Homo sapiens) 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:30903817 Slc51b Rat bosentan increases expression ISO SLC51B (Homo sapiens) 6480464 Bosentan results in increased expression of SLC51B mRNA CTD PMID:29761207 Slc51b Rat budesonide multiple interactions EXP 6480464 [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat budesonide increases expression ISO SLC51B (Homo sapiens) 6480464 Budesonide results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat caffeine increases phosphorylation ISO SLC51B (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of SLC51B protein CTD PMID:35688186 Slc51b Rat calcitriol decreases expression ISO SLC51B (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat calcitriol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat carbon nanotube increases expression ISO Slc51b (Mus musculus) 6480464 Nanotubes, Carbon results in increased expression of SLC51B mRNA CTD PMID:25620056 Slc51b Rat cefalotin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat CGP 52608 multiple interactions ISO SLC51B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC51B gene] CTD PMID:28238834 Slc51b Rat chenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:16423920|PMID:19562681|PMID:22178739|PMID:24703425|PMID:32152650|PMID:34589561 Slc51b Rat chenodeoxycholic acid multiple interactions EXP 6480464 [Chenodeoxycholic Acid binds to NR1H4 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat chenodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Chenodeoxycholic Acid results in increased expression of SLC51B mRNA; Chenodeoxycholic Acid results in increased expression more ... CTD PMID:16423920|PMID:19562681|PMID:22178739|PMID:24703425|PMID:25055961|PMID:27174168|PMID:32294204 Slc51b Rat chlorpromazine multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat cholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 Slc51b Rat cholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:22961653|PMID:25582706 Slc51b Rat cholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in more ... CTD PMID:22540009 Slc51b Rat choline multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Slc51b Rat chromium(6+) affects expression ISO Slc51b (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC51B mRNA CTD PMID:28472532 Slc51b Rat ciprofloxacin decreases expression ISO Slc51b (Mus musculus) 6480464 Ciprofloxacin results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat cisplatin multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC51B mRNA CTD PMID:27392435 Slc51b Rat cisplatin increases expression ISO SLC51B (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC51B mRNA CTD PMID:27392435|PMID:38498338 Slc51b Rat clofibrate decreases expression ISO Slc51b (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC51B mRNA CTD PMID:28973556 Slc51b Rat cyclosporin A increases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC51B mRNA CTD PMID:20106945|PMID:21632981|PMID:27989131 Slc51b Rat cyclosporin A decreases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC51B mRNA CTD PMID:25562108|PMID:32253466|PMID:34681664 Slc51b Rat cyclosporin A multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of SLC51B mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic more ... CTD PMID:27344345|PMID:32152650 Slc51b Rat DDE decreases expression ISO Slc51b (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51B mRNA CTD PMID:28392238 Slc51b Rat deoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Deoxycholic Acid results in increased expression of SLC51B; Deoxycholic Acid results in increased expression of more ... CTD PMID:22268002|PMID:25055961 Slc51b Rat deoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:32152650|PMID:34589561 Slc51b Rat deoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Deoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:21914718|PMID:25582706 Slc51b Rat deoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in increased expression of SLC51B mRNA] CTD PMID:21914718 Slc51b Rat dexamethasone multiple interactions EXP 6480464 [Dexamethasone binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat dexamethasone increases expression ISO SLC51B (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat dextran sulfate multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B more ... CTD PMID:29950665 Slc51b Rat dibenzofurans decreases expression ISO Slc51b (Mus musculus) 6480464 Dibenzofurans results in decreased expression of SLC51B mRNA CTD PMID:34254344 Slc51b Rat dioxygen increases expression ISO SLC51B (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC51B mRNA CTD PMID:24703425 Slc51b Rat epoxiconazole decreases expression ISO Slc51b (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC51B mRNA CTD PMID:35436446 Slc51b Rat ethyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 Slc51b Rat fidaxomicin multiple interactions ISO SLC51B (Homo sapiens) 6480464 Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake more ... CTD PMID:32294204 Slc51b Rat fipronil increases expression ISO SLC51B (Homo sapiens) 6480464 fipronil results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat fipronil multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat folic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Slc51b Rat folic acid decreases expression ISO Slc51b (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC51B mRNA CTD PMID:25629700 Slc51b Rat glycochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:32152650|PMID:32294204|PMID:34589561 Slc51b Rat glycocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:32152650|PMID:32294204|PMID:34589561 Slc51b Rat glycodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:32152650|PMID:34589561 Slc51b Rat glycyrrhetinate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat glycyrrhetinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat glycyrrhizinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat GW 4064 multiple interactions ISO Slc51b (Mus musculus) 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in more ... CTD PMID:20091679|PMID:22540009|PMID:28223344 Slc51b Rat GW 4064 increases expression ISO SLC51B (Homo sapiens) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:22178739 Slc51b Rat GW 4064 increases expression ISO Slc51b (Mus musculus) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:23178280|PMID:26655953|PMID:27609522 Slc51b Rat GW 4064 multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51B mRNA] CTD PMID:22178739 Slc51b Rat hydrogen peroxide affects expression ISO SLC51B (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC51B mRNA CTD PMID:20044591 Slc51b Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC51B mRNA CTD PMID:21396975 Slc51b Rat L-methionine multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Slc51b Rat lead(0) affects methylation ISO SLC51B (Homo sapiens) 6480464 Lead affects the methylation of SLC51B gene CTD PMID:31636367 Slc51b Rat leflunomide increases expression ISO SLC51B (Homo sapiens) 6480464 leflunomide results in increased expression of SLC51B mRNA CTD PMID:28988120 Slc51b Rat lithocholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:19562681|PMID:25055961 Slc51b Rat lithocholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:17256725|PMID:23034213 Slc51b Rat lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid binds to VDR protein] which affects the expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat lithocholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 NR1H3 protein inhibits the reaction [Lithocholic Acid results in increased expression of SLC51B mRNA]; SMAD3 more ... CTD PMID:17256725|PMID:23034213 Slc51b Rat manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC51B mRNA CTD PMID:28801915 Slc51b Rat mercury dichloride decreases expression ISO Slc51b (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 Slc51b Rat methyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 Slc51b Rat methylmercury chloride decreases expression ISO Slc51b (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 Slc51b Rat methyltestosterone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat metronidazole decreases expression ISO Slc51b (Mus musculus) 6480464 Metronidazole results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat N,N-diethyl-m-toluamide multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC51B mRNA CTD PMID:28801915 Slc51b Rat nefazodone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Slc51b Rat neomycin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27255380 Slc51b Rat obeticholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27939613 Slc51b Rat obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 Slc51b Rat obeticholic acid increases expression ISO Slc51b (Mus musculus) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:26655953 Slc51b Rat ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of SLC51B mRNA CTD PMID:30449730 Slc51b Rat okadaic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Okadaic Acid results in increased expression of SLC51B mRNA CTD PMID:38832940 Slc51b Rat oleanolic acid increases expression ISO Slc51b (Mus musculus) 6480464 Oleanolic Acid results in increased expression of SLC51B mRNA; Oleanolic Acid results in increased expression more ... CTD PMID:23948738 Slc51b Rat PCB138 multiple interactions ISO Slc51b (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Slc51b Rat perfluorobutanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorobutanesulfonic acid CTD PMID:26001962 Slc51b Rat perfluorohexanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorohexanesulfonic acid CTD PMID:26001962 Slc51b Rat perfluorooctane-1-sulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorooctane sulfonic acid CTD PMID:26001962 Slc51b Rat perfluorooctane-1-sulfonic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 Slc51b Rat perfluorooctanesulfonamide decreases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctanesulfonamide results in decreased expression of SLC51B mRNA CTD PMID:38953992 Slc51b Rat perfluorooctanoic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 Slc51b Rat phenethyl caffeate multiple interactions ISO Slc51b (Mus musculus) 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51B mRNA; more ... CTD PMID:28223344 Slc51b Rat phenobarbital increases expression ISO SLC51B (Homo sapiens) 6480464 Phenobarbital results in increased expression of SLC51B mRNA; Phenobarbital results in increased expression of SLC51B more ... CTD PMID:19084549|PMID:35881160 Slc51b Rat pirinixic acid increases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC51B mRNA CTD PMID:20813756 Slc51b Rat pirinixic acid decreases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC51B mRNA CTD PMID:23811191 Slc51b Rat pirinixic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Slc51b Rat pirinixic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Slc51b Rat prothioconazole decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole results in decreased expression of SLC51B mRNA CTD PMID:36007749 Slc51b Rat Prothioconazole-desthio decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole-desthio results in decreased expression of SLC51B mRNA CTD PMID:36007749 Slc51b Rat pyrazinecarboxamide multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 Slc51b Rat pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC51B mRNA; Pyrazinamide results in decreased expression of SLC51B more ... CTD PMID:27255380 Slc51b Rat quercetin decreases expression ISO SLC51B (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC51B mRNA CTD PMID:21632981 Slc51b Rat resorcinol decreases expression ISO SLC51B (Homo sapiens) 6480464 resorcinol results in decreased expression of SLC51B mRNA CTD PMID:22623647 Slc51b Rat resveratrol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC51B mRNA CTD PMID:23557933 Slc51b Rat rifampicin increases expression ISO SLC51B (Homo sapiens) 6480464 Rifampin results in increased expression of SLC51B mRNA CTD PMID:27199754 Slc51b Rat serpentine asbestos increases expression ISO SLC51B (Homo sapiens) 6480464 Asbestos, Serpentine results in increased expression of SLC51B mRNA CTD PMID:21148743 Slc51b Rat silicon dioxide decreases expression ISO SLC51B (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC51B mRNA CTD PMID:25895662 Slc51b Rat sodium arsenite decreases expression ISO SLC51B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:29301061 Slc51b Rat sodium arsenite decreases expression ISO Slc51b (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:37682722 Slc51b Rat sodium arsenite increases expression ISO SLC51B (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC51B mRNA CTD PMID:38568856 Slc51b Rat streptozocin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of SLC51B mRNA CTD PMID:29382564 Slc51b Rat Sunset Yellow FCF multiple interactions ISO SLC51B (Homo sapiens) 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:34589561 Slc51b Rat taurochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurochenodeoxycholic Acid; Fidaxomicin more ... CTD PMID:32294204 Slc51b Rat taurocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid; Fidaxomicin more ... CTD PMID:32294204 Slc51b Rat tauroursodeoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of SLC51B protein CTD PMID:36787806 Slc51b Rat tetrachloromethane decreases expression ISO Slc51b (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC51B mRNA CTD PMID:31919559 Slc51b Rat titanium dioxide multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B more ... CTD PMID:29950665 Slc51b Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC51B mRNA CTD PMID:33387578 Slc51b Rat triclosan decreases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in decreased expression of SLC51B mRNA CTD PMID:30510588 Slc51b Rat triclosan multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 Slc51b Rat triclosan increases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in increased expression of SLC51B mRNA CTD PMID:34681664 Slc51b Rat tris(2-butoxyethyl) phosphate affects expression ISO SLC51B (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC51B mRNA CTD PMID:29024780 Slc51b Rat ursodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 Slc51b Rat ursodeoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25582706 Slc51b Rat valproic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC51B mRNA CTD PMID:29154799